The study noted a price change of -31.7% for quadropoly and 47.4% for monopoly.
The agency will now give priority reviews to new generic drugs until there are at least 3 available.
Former pharma reps are educating doctors about costs of medications and encouraging the use of generic drugs.
Dermatologists receive variations in nature and amount of payments from pharmaceutical companies, with the top 1% receiving at least $93,622.
The FDA has just approved the drug, Exondys 51, to treat patients with a mutation of the dystrophin gene amenable to exon 51 skipping in DMD.
According to Mylan, the first generic version of EpiPen® will be distributed in several weeks in an attempt to further lower the costs of attaining this life-saving medication.
The pharmaceutical company has outlined steps to lower the financial burden of acquiring their products after price hike.